甲状腺结节和分化型甲状腺癌诊治指南(第二版)

Guidelines for the Diagnosis and Management of Thyroid Nodules and Differentiated Thyroid Cancer(Second Edition)

中国《甲状腺结节和分化型甲状腺癌诊治指南》(第二版)是在第一版(2012年版)的基础上进行的修订。参与第二版指南修订的国家级学会由4个增加为7个,内分泌科、甲状腺外科、肿瘤科、核医学科、超声医学科和病理科专家都参与了本指南的编撰,增加了指南的权威性。指南采用最佳的临床证据并综合专家意见给出了117条推荐,内容全面而系统。明确了甲状腺结节的筛查人群,增加了超声鉴别甲状腺结节良恶性的中国标准,提出了超声引导下的细针抽吸活检和粗针活检的适应证,对分化型甲状腺癌术前评估、术式、术后分期、随访、131I治疗、促甲状腺激素抑制治疗、靶向药物治疗以及新兴的治疗方法给予了比较全面和客观的修订。第二版指南将为进一步指导和规范甲状腺结节和甲状腺癌的诊断治疗发挥积极的推动作用。

The Chinese guidelines for the diagnosis and management of thyroid nodules and differentiated thyroid cancer(Second edition)were revised on the basis of the 2012 edition.The number of national societies involved in the revision increased from four to seven,endocrinology,thyroid surgery,oncology,nuclear medicine,ultrasound,and pathology,which enhanced the authority of the guidelines.The guideline is comprehensive and systematic with 117 recommendations based on the best clinical evidence and expert opinion.The guideline clarifies the population clusters for thyroid nodules screening,draws up the Chinese standard of ultrasound for differentiating benign and malignant thyroid nodules and proposes the indications of ultrasound-guided fine-needle aspirations biopsy and core needle biopsy.It effectuates a more comprehensive and objective revision for preoperative evaluation,surgical procedures,postoperative staging,follow-up strategy,131I therapy,thyroid stimulating hormone suppressive therapy,targeted medication,and emerging therapeutic methods for differentiated thyroid cancer.The edition will be an active impetus in improving the diagnosis and therapeutic landscape of thyroid nodules and differentiated thyroid cancer in China.